NASDAQ: XENE · Biotechnology
Over the past week, Xenon Pharmaceuticals (XENE) saw 11 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 50% bullish but is deeply split: News runs 100% bullish while X sits at just 0%. Wall Street is more constructive, with 20 of 20 analysts rating XENE a buy.
There is little buzz around XENE this week and little agreement on direction, which is why it reads as a Hold.
Wall Street’s 100% buy share sits next to a crowd that ranges from X at 0% to News at 100%. No other tracker puts the two side by side.
Across 20 analysts the consensus is a Strong Buy: 20 buy calls against 0 sell, with an average 12-month price target of $81.30.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits right on the neutral line, momentum is mixed and the 2 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
Analysts sit 50 points above the crowd average of 50%, the professionals are more constructive than retail. The split is inside the crowd: News reads 100% bullish while X sits at 0%, a 100-point spread that single-source trackers miss.
Over the 30-day window, Xenon Pharmaceuticals (XENE) buzz held subdued around 24.3 while the price drifted down 7.4% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 653K shares. Over the last 7 trading days, XENE lost 3.5%. Buzz activity in the recent week averaged 27.7 and was variable, swinging between 17.2 and 44.5. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 5 of the 17 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Reddit data for this stock this week.
No Polymarket data for this stock this week.
Query sentiment for XENE and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live XENE sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 04, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (20 / 0 / 0) |
| Crowd bullish (7d) | 50% |
| Avg price target | $81.30 |
| Most bullish source | News, 100% |
| Most bearish source | X, 0% |
| Sentiment spread | 100 pts |
| Mentions (7d) | 11 |
| Market cap | $5.85B |
| EPS · Beta | -$4.75 · 0.6 |
| Industry | Biotechnology |
Based on aggregated sentiment from X and News sources, Xenon Pharmaceuticals (XENE) currently carries an Adanos hold signal with 49/100 conviction. The current cross-source average reads 50% bullish across 2 active sources. Those sources contribute 11 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
The crowd reads split on Xenon Pharmaceuticals (XENE), averaging 50% bullish across 2 tracked sources over the last 7 days. The two ends of the range are News at 100% bullish and X at 0%, a 100-point spread. On the professional side, 20 of 20 analysts rate XENE a buy.
Of the 20 analysts covering Xenon Pharmaceuticals (XENE), 20 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $81.30. That puts the street ahead of the crowd, which averages 50% bullish.
Xenon Pharmaceuticals (XENE)'s cross-source average is mixed at 50% bullish. Source readings are split: 1 source leans bullish and 1 source leans bearish. News reads 100% bullish and x coverage is the most negative at 0% bullish. The combined signal points to broad mixed pressure with 49/100 conviction.
The cross-source average is mixed for Xenon Pharmaceuticals (XENE) at 50% bullish. Source readings are split: 1 source leans bullish and 1 source leans bearish. The most bearish reading is x at 0% bullish. The hold signal carries 49/100 conviction.
News is the dominant discussion channel with 8 mentions (73% of total volume). X contributes 3 mentions. The cross-source average is mixed at 50% bullish. Source readings are split: 1 source leans bullish and 1 source leans bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. XENE's hold signal at 49/100 conviction reflects a mixed cross-source average at 50% bullish. Source readings are split: 1 source leans bullish and 1 source leans bearish. It is a research shortcut, not financial advice.
The XENE sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key